Targeted therapy (for metastatic urological cancers)
Targeted Therapy Treatment Services in Delhi NCR
Welcome to Dr. Amitabh Singh’s specialized treatment services for targeted therapy in metastatic urological cancers.
Overview
Dr. Amitabh Singh, a renowned Uro-oncologist, specializes in providing personalized and effective targeted therapy for patients diagnosed with advanced urological malignancies. With his expertise and commitment to patient care, he offers advanced treatment options for individuals facing metastatic urological cancers.
Targeted Therapy
Targeted therapy is an advanced treatment approach designed to specifically target cancer cells in metastatic urological cancers, such as prostate, bladder, kidney, and testicular cancers. Unlike traditional chemotherapy, targeted therapy focuses on the unique genetic and molecular characteristics of cancer cells, inhibiting their growth and spread. Dr. Singh, Targeted Therapy Cancer Treatment Specialist Rohini, utilizes advanced diagnostic techniques, including : –
Through genetic testing, Dr. Singh, Targeted Therapy Cancer Treatment Doctor Delhi, identifies specific genetic mutations or alterations in your cancer cells. This information helps determine the most appropriate targeted therapy drugs for your treatment.
Dr. Singh, Targeted Therapy Cancer Treatment Specialist Rohini, identifies specific molecular targets in your cancer cells that play a critical role in their growth and survival. These targets include:
- Receptor Tyrosine Kinases (RTKs): Proteins involved in signaling pathways that regulate cancer cell growth and division.
- Epidermal Growth Factor Receptor (EGFR): A protein that promotes cell growth and division.
- Vascular Endothelial Growth Factor (VEGF): A protein that stimulates the growth of new blood vessels to supply nutrients to tumors.
- Poly (ADP-ribose) Polymerase (PARP): An enzyme involved in DNA repair.
- Receptor Tyrosine Kinases (RTKs): Proteins involved in signaling pathways that regulate cancer cell growth and division.
- Epidermal Growth Factor Receptor (EGFR): A protein that promotes cell growth and division.
- Vascular Endothelial Growth Factor (VEGF): A protein that stimulates the growth of new blood vessels to supply nutrients to tumors.
- Poly (ADP-ribose) Polymerase (PARP): An enzyme involved in DNA repair.
Treatment Process
Dr. Singh, Targeted Therapy Cancer Treatment Expert NCR, conducts a thorough consultation and evaluation, reviewing your medical history, performing a comprehensive assessment, and discussing your symptoms and concerns. Genetic testing and imaging studies may be performed to identify specific molecular targets in your cancer cells.
Based on the evaluation results, Dr. Singh, Targeted Therapy Cancer Treatment Surgeon RGCIRC, develops a personalized treatment plan tailored to your unique needs. This plan may include:
- Targeted Therapy Drugs: Dr. Singh prescribes medications that specifically target the identified molecular abnormalities in your cancer cells, such as:
- Tyrosine Kinase Inhibitors (TKIs): Medications that block specific proteins involved in cancer cell growth and division.
- Monoclonal Antibodies: Antibodies that attach to specific proteins on cancer cells, triggering an immune response against the tumor.
- PARP Inhibitors: Drugs that block the activity of PARP enzymes, preventing cancer cells from repairing their DNA.
- Targeted Therapy Drugs: Dr. Singh prescribes medications that specifically target the identified molecular abnormalities in your cancer cells, such as:
- Tyrosine Kinase Inhibitors (TKIs): Medications that block specific proteins involved in cancer cell growth and division.
- Monoclonal Antibodies: Antibodies that attach to specific proteins on cancer cells, triggering an immune response against the tumor.
- PARP Inhibitors: Drugs that block the activity of PARP enzymes, preventing cancer cells from repairing their DNA.
Targeted therapy drugs are usually administered orally in the form of pills or capsules. Dr. Singh, Targeted Therapy Cancer Treatment Specialist NCR, provides detailed instructions regarding dosage and timing. Regular follow-up appointments are scheduled to monitor your treatment response and make any necessary adjustments.
Dr. Singh, Targeted Therapy Cancer Treatment Doctor West Delhi, closely monitors your progress through regular follow-up appointments, imaging studies, and laboratory tests. The medical team provides support in managing potential side effects and addresses any concerns you may have.
Why Choose Dr. Amitabh Singh's Targeted Therapy Services ?
Dr. Singh, Targeted Therapy Cancer Treatment Specialist Rohini, is a highly skilled Uro-oncologist with extensive experience in providing targeted therapy for metastatic urological cancers. He stays updated with the latest advancements to offer the most effective treatments.
Dr. Singh, Targeted Therapy Cancer Treatment Expert NCR, believes in tailoring each treatment plan to suit your individual needs. By analyzing the molecular characteristics of your cancer, he designs a targeted therapy strategy specifically for you.
Dr. Singh, Targeted Therapy Cancer Treatment Doctor Delhi, and his team provide comprehensive care throughout your treatment journey, ensuring you receive the necessary support and guidance. Their goal is to maximize treatment effectiveness while minimizing side effects.
Dr. Singh's treatment center is equipped with state-of-the-art diagnostic and treatment technologies, enabling precise molecular profiling and targeted therapy administration.
Take the First Step Towards Recovery
If you or a loved one has been diagnosed with metastatic urological cancer and are considering targeted therapy, Dr. Amitabh Singh is here to help. Contact us today to schedule an Online Cancer Specialist Appointment and take the first step towards a personalized and effective treatment plan for your cancer.
Frequently Asked Questions
Chemotherapy and targeted therapy are two distinct treatments used against cancer cells. Chemotherapy involves the use of medications that target rapidly dividing cells, including cancer cells, but can also affect healthy cells, leading to side effects. In contrast, targeted therapy employs drugs that specifically target certain molecules or pathways in cancer cells, resulting in fewer side effects on healthy cells. Both treatments are often used in conjunction with other therapies, such as radiation, to optimize treatment outcomes. This multidisciplinary approach aims to maximize effectiveness while minimizing the toxicity to healthy cells. It is essential to determine the most suitable treatment plan based on the specific type and stage of cancer, and consultation with healthcare professionals is crucial in making informed decisions.
Targeted therapy is commonly used in advanced stages of many cancers. However, in certain types of cancer, it can also be utilized as a treatment option for early-stage cases. The availability and suitability of targeted therapy depend on the specific cancer type and its characteristics. It is worth noting that new drugs and treatment options are continually emerging, expanding the range of targeted therapy options.
Monoclonal antibodies are a key group of targeted therapy drugs used in cancer treatment. They are engineered molecules that specifically target proteins or receptors on cancer cells, inhibiting their growth or activating the immune system against them. Monoclonal antibodies can be used alone or combined with other treatments. New drugs in this category continue to emerge regularly, so it is essential to consult with a cancer specialist for the latest information and to determine the suitability of monoclonal antibodies for your specific cancer type.
While targeted therapy has proven effective in many cases, it does come with certain limitations. One drawback is the potential development of resistance by cancer cells. Resistance can occur when the target of the therapy undergoes changes, preventing the therapy from effectively interacting with it. Additionally, cancer cells can adapt and find alternative pathways for growth that are independent of the targeted molecule.
Targeted therapy is known to cause fewer side effects than chemotherapy as it selectively targets cancer cells while sparing nearby normal tissue. By specifically interfering with cancer-related molecules or pathways, targeted therapy minimizes damage to healthy cells, resulting in a reduced incidence and severity of side effects. However, it is important to recognize that targeted therapy can still have its own unique side effects, and the specific impact varies depending on the individual and the type of targeted therapy being administered.
Targeted therapy in cancer treatment involves the identification of specific targets on cancer cells, and the utilization of drugs that are customized to match the genetic instructions of those cells. These tailored drugs are designed to either directly eliminate cancer cells or disrupt the signaling pathways necessary for their growth. By precisely targeting the cancer cells and their unique genetic characteristics, targeted therapy aims to impede their ability to grow and proliferate.